An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia.

Publication Type:

Journal Article

Source:

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology (2013)

Keywords:

2013, Center-Authored Paper, Clinical Research Division, July 2013, Public Health Sciences Division, Vaccine and Infectious Disease Division

Abstract:

Additional drugs are needed for the treatment of cytomegalovirus (CMV) infection. Artesunate is an antimalarial drug that has activity against CMV in vitro and in a rodent model. Only a small number of case reports are available describing the clinical effects of artesunate on CMV infection, and these yielded inconsistent results.